Henry Schein (NASDAQ:HSIC) Issues Quarterly Earnings Results

Henry Schein (NASDAQ:HSIC) issued its quarterly earnings data on Tuesday. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04), Zacks reports. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the prior year, the firm earned $0.66 EPS. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. Henry Schein updated its FY 2025 guidance to 4.800-4.940 EPS and its FY25 guidance to $4.80-4.94 EPS.

Henry Schein Trading Down 2.3 %

NASDAQ:HSIC opened at $75.82 on Wednesday. The business has a 50 day simple moving average of $74.25 and a 200 day simple moving average of $72.43. The firm has a market capitalization of $9.45 billion, a P/E ratio of 31.20, a P/E/G ratio of 2.13 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.63.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Barrington Research reissued an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday. Jefferies Financial Group upped their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Wells Fargo & Company initiated coverage on Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. Eight investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.